Posted August 2, 2018 by mildasmoser
Aprezo (otezla) an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of active psoriatic arthritis and severe plaque psoriasis from Glenmark.
| Contact Email | [email protected] |
| Issued By | thomas shaw |
| Website | Apremilast price |
| Business Address | Los Angels |
| Country | United States |
| Categories | Business |
| Tags | apremilast price |
| Last Updated | August 2, 2018 |